Wroblewski, M <br/><br/>
Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B.  [electronic resource] 

 -  Nature communications  08 2017 
 - 269 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/s41467-017-00327-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Anti-Asthmatic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cromolyn Sodium--pharmacology<br/>Endothelial Cells--drug effects<br/>Extracellular Matrix--drug effects<br/>Fibroblast Growth Factor 1--drug effects<br/>Fibroblast Growth Factor 2--drug effects<br/>Granulocyte-Macrophage Colony-Stimulating Factor--drug effects<br/>Granzymes--metabolism<br/>Human Umbilical Vein Endothelial Cells<br/>Laminin--metabolism<br/>Mast Cells--drug effects<br/>Mice<br/>Neoplasms--blood supply<br/>Neovascularization, Pathologic--metabolism<br/>Vascular Endothelial Growth Factor A--drug effects<br/>Vascular Endothelial Growth Factor Receptor-2--drug effects<br/>Vitronectin--metabolism